While Citi has maintained its 'buy' call for Cipla, it noted that a further delay in resolving issues at the Goa facility ...

Citi’s commentary comes as China-based pharma company Jiangsu Hengrui has received approval for Paclitaxel, the generic ...

Citi Maintains Buy On Cipla | Goa Unit Warning Letter Under Scanner#cipla #ciplastocks #brokerageradar #citi #businessnews ...

The Nifty Pharma index has so far this year gained 54.42 percent while the benchmark Nifty advanced 26.94 percent in the same ...

Discover the Cipla Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock.

A media report said that the US Center for Medicare and Medicaid released a preliminary list of 101 generic drugs.

The Indian market is expected to consolidate on Thursday, influenced by mixed global cues. The Nifty futures experienced a ...

Stay up-to-date with the Cipla Stock Liveblog, your trusted source for real-time updates and thorough analysis of a prominent ...

Here's what Goldman Sachs, Jefferies, JPMorgan, Citi, Morgan Stanley, CLSA, and Nomura make of stocks such as Bandhan Bank, ...

UBS highlights growth opportunities for Sun Pharma and Cipla while raising alarms about profitability pressures in the Indian ...

Investec emphasised the significant potential Cipla holds in the GLP-1 (Glucagon-like peptide) space, a hormone crucial for ...

Indian shares ended slightly lower on Friday as TCS' Q2 earnings failed to impress markets. A nearly 4 percent surge in oil prices ...